Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Bacterial-based systems for expression and purification of recombinant Lassa virus proteins of immunological relevance.

Branco LM, Matschiner A, Fair JN, Goba A, Sampey DB, Ferro PJ, Cashman KA, Schoepp RJ, Tesh RB, Bausch DG, Garry RF, Guttieri MC.

Virol J. 2008 Jun 6;5:74. doi: 10.1186/1743-422X-5-74.

2.

Uncoupling GP1 and GP2 expression in the Lassa virus glycoprotein complex: implications for GP1 ectodomain shedding.

Illick MM, Branco LM, Fair JN, Illick KA, Matschiner A, Schoepp R, Garry RF, Guttieri MC.

Virol J. 2008 Dec 23;5:161. doi: 10.1186/1743-422X-5-161.

3.

Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever.

Branco LM, Grove JN, Geske FJ, Boisen ML, Muncy IJ, Magliato SA, Henderson LA, Schoepp RJ, Cashman KA, Hensley LE, Garry RF.

Virol J. 2010 Oct 20;7:279. doi: 10.1186/1743-422X-7-279.

4.

Shedding of soluble glycoprotein 1 detected during acute Lassa virus infection in human subjects.

Branco LM, Grove JN, Moses LM, Goba A, Fullah M, Momoh M, Schoepp RJ, Bausch DG, Garry RF.

Virol J. 2010 Nov 9;7:306. doi: 10.1186/1743-422X-7-306.

5.
6.

Development of recombinant nucleoprotein-based diagnostic systems for Lassa fever.

Saijo M, Georges-Courbot MC, Marianneau P, Romanowski V, Fukushi S, Mizutani T, Georges AJ, Kurata T, Kurane I, Morikawa S.

Clin Vaccine Immunol. 2007 Sep;14(9):1182-9. Epub 2007 Jul 18.

7.

Genetic diversity among Lassa virus strains.

Bowen MD, Rollin PE, Ksiazek TG, Hustad HL, Bausch DG, Demby AH, Bajani MD, Peters CJ, Nichol ST.

J Virol. 2000 Aug;74(15):6992-7004.

8.

Small-Molecule Fusion Inhibitors Bind the pH-Sensing Stable Signal Peptide-GP2 Subunit Interface of the Lassa Virus Envelope Glycoprotein.

Shankar S, Whitby LR, Casquilho-Gray HE, York J, Boger DL, Nunberg JH.

J Virol. 2016 Jul 11;90(15):6799-807. doi: 10.1128/JVI.00597-16. Print 2016 Aug 1.

9.

Old and New World arenaviruses share a highly conserved epitope in the fusion domain of the glycoprotein 2, which is recognized by Lassa virus-specific human CD4+ T-cell clones.

Meulen Jt, Badusche M, Satoguina J, Strecker T, Lenz O, Loeliger C, Sakho M, Koulemou K, Koivogui L, Hoerauf A.

Virology. 2004 Mar 30;321(1):134-43.

10.

Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigs.

Jiang X, Dalebout TJ, Bredenbeek PJ, Carrion R Jr, Brasky K, Patterson J, Goicochea M, Bryant J, Salvato MS, Lukashevich IS.

Vaccine. 2011 Feb 1;29(6):1248-57. doi: 10.1016/j.vaccine.2010.11.079. Epub 2010 Dec 8.

11.

Antigenic relatedness between arenaviruses defined at the epitope level by monoclonal antibodies.

Ruo SL, Mitchell SW, Kiley MP, Roumillat LF, Fisher-Hoch SP, McCormick JB.

J Gen Virol. 1991 Mar;72 ( Pt 3):549-55.

PMID:
1706408
12.

Evolution of recombinant lymphocytic choriomeningitis virus/Lassa virus in vivo highlights the importance of the GPC cytosolic tail in viral fitness.

Sommerstein R, Ramos da Palma J, Olschläger S, Bergthaler A, Barba L, Lee BP, Pasquato A, Flatz L.

J Virol. 2014 Aug;88(15):8340-8. doi: 10.1128/JVI.00236-14. Epub 2014 May 14.

13.

Expression in Escherichia coli and purification of soluble forms of the F protein of bovine respiratory syncytial virus.

Naval J, Piñol J, Rebordosa X, Serra-Hartmann X, Pérez-Pons JA, Querol E.

Protein Expr Purif. 1997 Mar;9(2):288-94.

PMID:
9056494
14.

Expression of an antigenic polypeptide of the human parvovirus B19.

Eiffert H, Köchel HG, Heuer M, Tratschin JD, Thomssen R.

Med Microbiol Immunol. 1990;179(4):169-75.

PMID:
2175835
15.

A bio-engineered rubella E1 antigen.

Terry GM, Ho-Terry L, Londesborough P, Rees KR.

Arch Virol. 1989;104(1-2):63-75.

PMID:
2647062
16.

Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays.

Ali A, Nisar M, Idrees M, Rafique S, Iqbal M.

Int J Infect Dis. 2015 May;34:84-9. doi: 10.1016/j.ijid.2015.03.010. Epub 2015 Mar 18.

17.
18.

Antiviral activity of a small-molecule inhibitor of arenavirus glycoprotein processing by the cellular site 1 protease.

Urata S, Yun N, Pasquato A, Paessler S, Kunz S, de la Torre JC.

J Virol. 2011 Jan;85(2):795-803. doi: 10.1128/JVI.02019-10. Epub 2010 Nov 10.

19.

Escherichia coli expressed herpes simplex virus gG1 and gG2 proteins in ELISA and immunoblotting assays.

Kakkanas A, Papadogeorgaki H, Manservigi R, Miriagou V, Georgopoulou U, Mavromara P.

Intervirology. 1995;38(6):346-51.

PMID:
8880385
20.

The role of proteolytic processing and the stable signal peptide in expression of the Old World arenavirus envelope glycoprotein ectodomain.

Burri DJ, Pasquato A, da Palma JR, Igonet S, Oldstone MB, Kunz S.

Virology. 2013 Feb 5;436(1):127-33. doi: 10.1016/j.virol.2012.10.038. Epub 2012 Dec 4.

Supplemental Content

Support Center